Related Experiment Videos
Intra-S-phase checkpoint activation by direct CDK2 inhibition
Yonghong Zhu1, Carmen Alvarez, Ronald Doll
1Molecular Oncology Laboratory, Department of Discovery Research, DNAX Research, Inc., Palo Alto, CA 94304, USA. yonghong.zhu@dnax.org
Molecular and Cellular Biology
|July 1, 2004
Summary
Loss of Cyclin-Dependent Kinase 2 (CDK2) activity triggers an intra-S-phase checkpoint, activating p53 and leading to genomic instability. This disruption can cause DNA rereplication, highlighting CDK2's role in maintaining cell cycle integrity.
Area of Science:
- Cell Biology
- Molecular Biology
- Genomics
Background:
- Cell cycle checkpoints are crucial for genomic integrity.
- Cyclin-Dependent Kinase 2 (CDK2) plays a role in cell cycle progression.
Purpose of the Study:
- To investigate the role of CDK2 activity in maintaining genomic stability.
- To elucidate the molecular mechanisms underlying CDK2 inhibition-induced checkpoint activation.
Main Methods:
- Inhibition of CDK2 activity in cells.
- Analysis of cell cycle progression and DNA content.
- Western blotting to detect protein phosphorylation and activation of downstream substrates (p53, p21, H2AX, NBS1, CHK1, CHK2).
- Assessment of minichromosome maintenance complex loading onto chromatin.
Main Results:
- CDK2 inhibition activates an intra-S-phase checkpoint.
- p53-p21 response is triggered via ATM- and ATR-dependent p53 phosphorylation.
- Increased phosphorylation of ATM/ATR downstream substrates (H2AX, NBS1, CHK1, CHK2).
- Unexpected loading of the minichromosome maintenance complex onto chromatin during S phase.
- Increased cells with >4N DNA content, even in the absence of p53, indicating potential rereplication.
Conclusions:
- CDK2 is essential for maintaining genomic stability.
- CDK2 disruption activates an ATM- and ATR-dependent intra-S-phase checkpoint.
- CDK2 inhibition can lead to DNA rereplication and genomic instability.